Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felis-induced gastritis in mice

Digestive Diseases and Sciences

Volumn 44, Issue 1, 1999, Pages 108-115

  Lichtenberger, Lenard M ^a,b,c   Dial, Elizabeth J ^a,b,c   Ottlecz, Anna ^a,b,c   Romero, Jimmy J ^a,b,c   Lechago, Juan ^a,b,c   Fox, James G ^a,b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Gastritis; Helicobacter; Phospholipase A2; Phospholipids; Surface hydrophobicity

Indexed keywords

BISMUTH CITRATE; METRONIDAZOLE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPID; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER FELIS; HYDROPHOBICITY; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; STOMACH JUICE; STOMACH PARIETAL CELL;

ANIMALS; BISMUTH; DISEASE MODELS, ANIMAL; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HYDROGEN-ION CONCENTRATION; MICE; MICE, INBRED C57BL; ORGAN SIZE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A; PHOSPHOLIPIDS; STOMACH;

EID: 0032947483     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026610418663     Document Type: Article

References (26)

1. 1. Moss SJ: Helicobacter pylori and peptic ulcers: the current position. Gut 33:289-292, 1992
2. 2. Lambert JR, Lin SK: Prevalence/disease correlates of H. pylori. In Helicobacter pylori: Basic Mechanisms to Clinical Cure. RH Hunt, GNJ Tytgat (eds). Dordrecht, Kluwer Academic Publishers, 1994, pp 95-112
3. 3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1131, 1991
4. 4. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Helicobacter pylori. In Schistosomes, Liver Flukes and Helicobacter pylori. 61 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, International Agency for Research on Cancer, 1994
5. 5. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomachs of patients with gastritis and peptic ulceration. Lancet 1:1311-1315, 1984
6. 6. Hills B, Butler BD, Lichtenberger LM: Gastric mucosal barrier: The hydrophobic lining to the lumen of the stomach. Am J Physiol 244:G56l-G568, 1983
7. 7. Lichtenberger LM: The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol 57:565-583, 1995
8. 8. Spychal RT, Goggin PM, Marrero JM, Saverymuttu SH, Yu CW, Corbishley CM, Maxwell JD, Nothfield, TC: Surface hydrophobicity of gastric mucosa in peptic ulcer disease. Gastroenterology 98:1250-1254, 1990
9. 9. Goggin PM, Marrero JM, Spychal RI, Jackson PA, Corbishley CM, Northfield TC: Surface hydrophobicity of the gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication. Gastroenterology 103:1486-1490, 1992
10. 10. Nardone G, D'Armieto F, Corso G, Civiletti C, Coscione P: Lipids of human gastric mucosa: Effect of inflammatory infiltrates, Helicobacter pylori, infection and non-alcoholic cirrhosis. Gastroenterology 107:362-368, 1994
11. 11. Asante M, Ahmed H, Patel P, Davis T, Finlayson C, Mendall M, Northfield TC: Gastric mucosal hydrophobicity in duodenal ulceration: Role of Helicobacter pylori infection density and mucus lipids. Gastroenterology 113:449-454, 1997
12. 12. Slomiany BL, Kasinathan C, Slomiany A: Lipolytic activity of Campylobacter pylori: Effects of colloidal bismuth subcitrate (De-Nol). Am J Gastroenterol 84:1273-1277, 1989
13. 13. Ottlecz A, Romero JJ, Hazell SL, Graham DY, Lichtenberger LM: Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Dig Dis Sci 38:2071-2080, 1993
14. 14. Lee A, Fox JG, Murphy J: A small animal model of human Helicobacter pylori active gastritis. Gastroenterology 99:1315-1323, 1990
15. 15. Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, Wang TC: Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 110:155-166, 1996
16. 16. Hazell SL, Borody TJ, Gall A, Lee A: Campylobacter pyloridis gastritis. Am J Gastroenterol 82:292-296, 1987
17. 17. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917, 1959
18. 18. Rouser G, Siratos AN, Fleisher S: Quantitative analysis of phospholipids by thin layer chromatography and phosphorus analysis of spots. Lipids 1:85-86, 1966
19. 19. Skipski U, Peterson RF, Sanders J, Barclay M: Thin-layer chromatography of phospholipids using silica gel without calcium binder. J Lipid Res 4:227-228, 1963
20. 2 activity of post-heparin plasma: Rapid and sensitive assay and partial characterization. Anal Biochem 114:64-70, 1981
21. 21. Mobley HL: Helicobacter pylori factors associated with disease development. Gastroenterology 113:S21-S28, 1997
22. 22. Covacci A: Mobilis in mobile: Unexpected flexibility and quantum leaps in the Helicobacter pylori genome. In Helicobacter pylori: Basic Mechanisms to Clinical Cure 1996. RH Hunt, GNJ Tytgat (eds). Dordrecht, Kluwer Academic Publishers, 1996, pp 40-49
23. 23. Ernst PB, Crowe SE, Reyes VE: How does Helicobacter pylori cause mucosal damage? The inflammatory response. Gastroenterology 113:S35-S42, 1997
24. 24. Genta RM: Helicobacter pylori; inflammation, mucosal damage and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology 113:S51-A55, 1997
25. 25. Lichtenberger LM, Romero JJ: Effect of ammonium ion on the hydrophobic barrier properties of the gastric mucus gel layer: Implications on the role of ammonium in H. pylori-induced gastritis. J Gastroenterol Hepatol 9:S13-S19, 1994
26. 2 show altered apoptosis and differentiation with Helicobacter felis Infection. Gastroenterology 114:675-689, 1998